DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Twardowski P, Atkinson S, Boldt-Houle D. et al.
Late dosing of luteinizing hormone-releasing hormone agonists (LHRH) and
testosterone (T) levels >20 ng/dL in prostate cancer (PCa).
Journal of Clinical Oncology 2020;
38: 31-31
We do not assume any responsibility for the contents of the web pages of other providers.